IL102365A0 - Substituted triazolinones,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted triazolinones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102365A0
IL102365A0 IL102365A IL10236592A IL102365A0 IL 102365 A0 IL102365 A0 IL 102365A0 IL 102365 A IL102365 A IL 102365A IL 10236592 A IL10236592 A IL 10236592A IL 102365 A0 IL102365 A0 IL 102365A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
substituted triazolinones
triazolinones
Prior art date
Application number
IL102365A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL102365A0 publication Critical patent/IL102365A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL102365A 1991-07-03 1992-06-30 Substituted triazolinones,their preparation and pharmaceutical compositions containing them IL102365A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72572091A 1991-07-03 1991-07-03
US81289191A 1991-12-20 1991-12-20

Publications (1)

Publication Number Publication Date
IL102365A0 true IL102365A0 (en) 1993-01-14

Family

ID=27111208

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102365A IL102365A0 (en) 1991-07-03 1992-06-30 Substituted triazolinones,their preparation and pharmaceutical compositions containing them

Country Status (7)

Country Link
EP (1) EP0526001A1 (fr)
JP (1) JPH05294947A (fr)
AU (1) AU648677B2 (fr)
CA (1) CA2072775A1 (fr)
IE (1) IE922164A1 (fr)
IL (1) IL102365A0 (fr)
WO (1) WO1993001177A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776946A (en) * 1995-08-28 1998-07-07 Mcgeer; Patrick L. Peripheral benzodiazepine receptor ligands as antiinflammatory agents
WO2000021532A1 (fr) * 1998-10-15 2000-04-20 Merck & Co., Inc. Inhibition de la resorption osseuse
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
KR100389670B1 (ko) * 2000-12-21 2003-07-02 주식회사 티씨 싸이언스 노화 방지를 위한 새로운 레티놀 유도체 및 그 제조방법
CA2456034A1 (fr) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Medicaments a liberation continue
KR20010088633A (ko) * 2001-08-14 2001-09-28 김진경 비타민c를 혼합한 향액의 이용 방법
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
CA3089569C (fr) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (fr) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
AR108906A1 (es) 2016-06-29 2018-10-10 Bristol Myers Squibb Co Heterociclos de biarilmetilo
WO2023066348A1 (fr) * 2021-10-21 2023-04-27 年衍药业(上海)有限公司 Antagoniste double et son utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0409332A3 (en) * 1989-07-19 1991-08-07 Merck & Co. Inc. Substituted triazoles as angiotensin ii antagonists
EP0412594B1 (fr) * 1989-07-28 1996-01-03 Merck & Co. Inc. Triazolinones, triazolinethiones et triazolinimines substituées comme antagonistes d'angiotensine II
CA2109524A1 (fr) * 1991-05-10 1992-11-11 Prasun K. Chakravarty Derives acides d'aralkyltriazole, antagonistes de l'angiotensine ii

Also Published As

Publication number Publication date
EP0526001A1 (fr) 1993-02-03
AU1938792A (en) 1993-01-07
IE922164A1 (en) 1993-01-13
JPH05294947A (ja) 1993-11-09
AU648677B2 (en) 1994-04-28
WO1993001177A1 (fr) 1993-01-21
CA2072775A1 (fr) 1993-01-04

Similar Documents

Publication Publication Date Title
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL102638A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL103053A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
IL99225A0 (en) 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
IL97050A0 (en) 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation
IL102292A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
IL98499A0 (en) Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them
IL98542A0 (en) Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL102365A0 (en) Substituted triazolinones,their preparation and pharmaceutical compositions containing them
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
IL102337A0 (en) Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them
IL103502A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL102500A0 (en) 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
IL105774A0 (en) Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
IL101164A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL105370A0 (en) Propenoyl-imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL103698A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL103926A0 (en) Quinolylmethoxyphenyl-acetamides,their preparation and pharmaceutical compositions containing them
IL102666A0 (en) Quinolin-2-yl-methoxybenzyl-hydroxyureas,their preparation and pharmaceutical compositions containing them